Skip to main content
Voices From ASCO 2025
From Survivor to Advocate Part 2: Maimah Karmo on Her Journey and Tigerlily Foundation’s Life-Changing Programs
Read More
Voices From ASCO 2025
From Survivor to Advocate Part 1: Maimah Karmo on Her Journey and Tigerlily Foundation’s Life-Changing Programs
Read More
ADC Therapy
Case-Based Exchanges
Management of Adverse Events in ADC Therapy: A Case-Based Exchange
Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, CPEL
Read More
Voices From ASCO 2025
Advancing Patient Support Part 2: Dr. Shanthi Sivendran on the American Cancer Society’s Mission and Impact
Read More
Voices From ASCO 2025
Advancing Patient Support Part 1: Dr. Shanthi Sivendran on the American Cancer Society’s Mission and Impact
Read More
Management of Adverse Events in Antibody–Drug Conjugate Therapy: A Critical Role for Nurses
Read More
Voices From ASCO 2025
Pioneering Progress in Lung Cancer: Dr. Greg Kalemkerian on Transformative Treatments
Read More
Voices From ASCO 2025
Shaping the Future of Cancer Care: Dr. Omid Hamid on Breakthroughs in Immuno-Oncology
Read More
Pharmacists at the Forefront: Proactive Management of Adverse Events in ADC Therapy
Read More
Original Research, Venetoclax, Chemotherapy, Leukemia
Evaluation of Outcomes and Adverse Events of a Hypomethylating Agent Plus Venetoclax Versus 7+3 Induction Chemotherapy in Patients Aged 50 to 70 Years
Robin Tumlinson, PharmD; Erin Kennedy, PharmD, BCOP; Alice Parish, MSPH; Alaattin Erkanli, PhD
Read More
Page 11 of 198
Results 101 - 110 of 1973